Theacrine Cognitive Performance Randomized Trial: What the Evidence Says

Quick Answer

Theacrine Cognitive Performance Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Evidence also indicates that caffeine can exert complementary effects when combined with other stimulants or nutrients, such as carbohydrate gels or gum-based formulations. [Jovanov Pavle (2025); evidence level 4]
• Additionally, caffeine-induced adenosine blockade alters autonomic nervous system activity, resulting in increased systolic blood pressure and heart rate, particularly during physical activity. [Jovanov Pavle (2025); evidence level 4]
• Similarly, Cintineo and colleagues observed that CTC and caffeine supplementation improved vigilance in tactically trained personnel compared to placebo. [Lints Blaine S. (2025); evidence level 4]
• No significant differences were found between the post-supplement and 30-min post-exercise evaluations or between the immediate and 30-min post-exercise evaluations. [Lints Blaine S. (2025); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For theacrine cognitive performance randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Jovanov Pavle (2025). Theacrine as a novel ergogenic aid: impact on canoe sprint performance. DOI: 10.1080/15502783.2025.2590097. PMCID: PMC12667338. PMID: 41320283. License: https://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access.... https://pmc.ncbi.nlm.nih.gov/articles/PMC12667338/
• Lints Blaine S. (2025). A caffeine and theacrine combination improves cognitive performance in tactical personnel under physically fatiguing conditions. DOI: 10.1080/15502783.2025.2536146. PMCID: PMC12284986. PMID: 40693646. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12284986/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.